GSTM1 and non-small cell lung carcinoma: Results of a unique study conducted by Joerger et al. 31 showed no associations between GSTM1 and GSTP1 A313G (Ile105Val) genotypes with CDDP pharmacokinetics in advanced non-small-cell lung cancer patients.